The FDA is continuing its efforts to build and leverage strong working relationships with state regulators in our collective efforts to oversee drug compounding. With the […]

English ¿Qué es la semaglutida? La semaglutida pertenece a una clase de medicamentos conocidos como agonistas de los receptores del péptido-1 similar al glucagón (GLP-1). Imita […]

On This Page Date: November 12, 2024 Time: 11:00 AM – 12:00 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT (Hosted […]

Reference #: FEI 1950348 Product: Drugs Recipient: Recipient Name Mr. Richard A. Gilbert Recipient Title President Marcus Research Laboratory, Inc. 1820 Delmar Blvd.St. Louis, MO 63103United […]

Delivery Method: UPS Product: Drugs Recipient: Recipient Name Mr. Richard A. Gilbert Recipient Title President Marcus Research Laboratory, Inc. 1820 Delmar BoulevardSaint Louis, MO 63103United States […]

Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Larry Mills Recipient Title President Organa International Corp. 533 N 1650 WSpringville, UT 84663United States […]

Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Christopher W. Shade, PhD Quicksilver Scientific 1960 Cherry StreetLouisville, CO 80027United States Issuing Office: Office […]

On October 3, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with platinum-doublet chemotherapy as neoadjuvant treatment, followed by single-agent nivolumab […]

Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Bruce D. Curtis/Marianne L. Curtis Recipient Title Co-owner(s) Living Foods LLC 1456 Marilee Dr.Lawrence, KS […]